Matrix Laboratories Limited
Records under this name other than patents Matrix Laboratories Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Matrix Laboratories Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,367,080 | Pharmaceutical formulation for use in HIV therapy Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,143,435 | One pot process for the preparation of candesartan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,344,159 | Carvedilol phosphate sesquihydrate Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,026,356 | Process for the large scale production of Stavudine Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,048,904 | Process for the preparation of olmesartan medoxomil Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,049,009 | Process for the preparation of Tenofovir Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,258,312 | Process for preparing pure valsartan Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,309,723 | Preparation of Zopiclone and its enantiomerically enriched isomer Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,247,568 | Process for the preparation of pure rabeprazole Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 8,318,930 | Process for preparing polymorphic forms of (S)-6-chloro-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one Formerly held In force · From the USPTO record | In force | From the USPTO record |